|
|
|
CAS# :269055-15-4 |
Catalog# :SWA0003 |
Alias : 4-(6-Amino-5-bromo-2-(4-cyanoanilino)pyrimidin-4-yloxy)-3,5-dimethylbenzonitrile;TMC 125 |
Molecular Formula : C20H15BrN6O |
Molecular Weight : 435.28 |
Purity : 97% |
Properties : Off-white solid |
BoilingPoint :637.4 °C at 760 mmHg |
Loss on drying :0.1% |
Use: Etravirine is a pharmaceutical drug, developed by Tibotec, for the treatment of HIV infection. It is a second-generation non-nucleoside reverse transcriptase inhibitor (NNRTI) with higher potency, longer half-life and reduced side-effect profile compared with older NNRTIs, such as efavirenz. |
|
|
|